Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...

Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the ...

Johnson & Johnson delivered a "beat and raise" quarter. Results were bolstered by the new acquisition of Intra-Cellular, ...

The ASTCT Translational Science Training Course is designed to meet a critical need in cellular therapy by providing structured support for early-stage researchers in laboratory and translational ...

Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, 2025, authorizes licensed physicians to administer stem cell therapies to ...

Florida's new law allows physicians to offer investigational stem cell therapies for orthopedics, wound care, and pain management.

Integrating innovative design strategies, computational modeling, single-cell omics, and advanced 3D BBB models will accelerate the development of precision FNA-based therapies.

The FDA has eliminated a safety monitoring requirement and eased certain restrictions that had been in place since CAR T-therapies first reached the market in 2017. The agency and financial ...

FDA approved label changes for Breyanzi and Abecma, easing access by reducing monitoring rules and eliminating REMS safety program requirements.